It’s always encouraging to hear about new treatments for little-known, but impactful diseases. Today, we’re turning our attention to one you may be aware of already: hidradentis.
What is it?
Hidradentis supportiva (HS) is a very disabling disease, whereby lumps develop under parts of the skin that rub together, such as the groin, armpits, between the buttocks. These lumps are usually very painful, and will often break open and drain foul-smelling pus. It can be very disfiguring and sexually disabling as well. It tends to start after puberty, and will only worsen over time.
What’s the current situation?
HS is almost impossible for some to get under control and they have very limited options. However, from my experience, I have managed to stabilize the condition in my practice using medication and altering skin care routines. Rarely, patients will have surgery to strategically remove the groin or armpit skin involved in the process, but HS will often return.
Tell me about this new treatment!
One year ago, our practice got approval for a patient to use a new treatment called Humira and recently, the FDA just approved it as well. It is the first and only FDA-approved therapy to treat HS amongst adults - that’s a big deal! We were able to use this for a patient with severe HS, and he actually responded well to it, which was amazing. The only downside? It isn’t cheap.
However, it has more than one use. Humira has also been approved to help treat moderate to severe rheumatoid arthritis and polyarticular juvenile idiopathic arthritis, psoriatic arthritis, Crohn’s disease, ankylosing spondylitis, severe ulcerative colitis, and moderate to severe chronic plaque psoriasis.
We’re extremely excited to have a new treatment approved and available to our patients.